Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus

Clinical trial NCT00752999 · WITHDRAWN

Trial details

NCT number: NCT00752999
Sponsor: Rigel Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2008-11-01
Primary completion: 2009-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.